Therapeutic control of hyperlipidemia in the prevention of coronary atherosclerosis: A review of results from recent clinical trials

This publication has 26 references indexed in Scilit:

• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
  Journal of the American College of Cardiology, 1986
• SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
  The Lancet, 1986
• The Pathogenesis of Atherosclerosis — An Update
  New England Journal of Medicine, 1986
• Secondary prevention and lipid lowering: Results and implications
  American Heart Journal, 1985
• Primary prevention of coronary heart disease by lowering lipids: Results and implications
  American Heart Journal, 1985
• Review of Primary Prevention Trials of Coronary Heart Disease
  Acta Medica Scandinavica, 1985
• The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
  Circulation, 1979